CA2984736A1 — Nasal formulations of metoclopramide
Assigned to Evoke Pharma Inc · Expires 2010-07-01 · 16y expired
What this patent protects
Previous nasal solutions of rnetoclopramide take on a yellow to brown color under accelerated stability conditions. The present invention provides pharmaceutical compositions of metoclopramide formulated for nasal administration, which rernain stable and/or colorless upon storage…
USPTO Abstract
Previous nasal solutions of rnetoclopramide take on a yellow to brown color under accelerated stability conditions. The present invention provides pharmaceutical compositions of metoclopramide formulated for nasal administration, which rernain stable and/or colorless upon storage over a period of time. Also provided are uses of the pharmaceutical compositions for treating disorders that are treatable with metoclopramide.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.